<DOC>
	<DOCNO>NCT02436681</DOCNO>
	<brief_summary>Miromatrix Medical develop MIROMESH® - new , noncrosslinked , acellular mesh derive highly vascularized porcine liver . MIROMESH receive FDA 510 ( k ) clearance indication reinforcement soft tissue March 31 , 2014 K134033 . This study serve provide clinician high-quality clinical data order provide high degree confidence select MIROMESH hiatal hernia repair .</brief_summary>
	<brief_title>Miromatrix Biological Mesh Hiatal Hernia Repair</brief_title>
	<detailed_description />
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Hiatal</mesh_term>
	<criteria>18 80 year old day study enrollment able willing sign consent form comply study visit procedure able undergo elective laparoscopic hiatal hernia repair free cognitive speech impairment document , symptomatic type II III hernia ≥5cm axial/vertical dimension commit nonsmoking least 4 week prior procedure previous operation esophagus stomach sensitivity porcine material pregnant plan pregnant within next 2 year immunocompromised risk immunosuppression ( i.e . HIV positive , experience organ rejection , recent anticipate chemotherapy recipient ) determine Investigator require emergent operation acute gastric volvulus strangulation American Society Anesthesiology ( ASA ) class 4 great BMI ≥40 life expectancy le 2 year time enrollment associate gastrointestinal disease require extensive medical surgical intervention might interfere quality life assessment ( e.g . Crohn 's disease ) condition opinion Investigator would preclude use study device , preclude subject complete followup requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>